Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Drug Discov. 2012 Dec;11(12):937-57. doi: 10.1038/nrd3871.

Protein kinase C, an elusive therapeutic target?

Author information

1
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California 94305-5174, USA. mochly@stanford.edu

Abstract

Protein kinase C (PKC) has been a tantalizing target for drug discovery ever since it was first identified as the receptor for the tumour promoter phorbol ester in 1982. Although initial therapeutic efforts focused on cancer, additional indications--including diabetic complications, heart failure, myocardial infarction, pain and bipolar disorder--were targeted as researchers developed a better understanding of the roles of eight conventional and novel PKC isozymes in health and disease. Unfortunately, both academic and pharmaceutical efforts have yet to result in the approval of a single new drug that specifically targets PKC. Why does PKC remain an elusive drug target? This Review provides a short account of some of the efforts, challenges and opportunities in developing PKC modulators to address unmet clinical needs.

PMID:
23197040
PMCID:
PMC3760692
DOI:
10.1038/nrd3871
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center